Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XL999 in Non-Small-Cell Lung Cancer
NCT00277329Phase 2Terminated
- Sponsor
- Symphony Evolution
- Start
- Dec 2005
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of xl999 in non-small cell lung cancer (NSCLC), sponsored by Symphony Evolution. Started Dec 2005; status: terminated.
02
Drugs
xl999
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00277329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00277329.